Literature DB >> 28197697

The alpha-herpesviridae in dermatology : Varicella zoster virus.

L El Hayderi1, A Rübben2, A F Nikkels3.   

Abstract

The second part of this publication deals with varicella zoster virus (VZV) and presents an overview of new, rare, and atypical clinical manifestations, including photolocalized varicella, hemorrhagic bullae during varicella, the implication of VZV in immunoglobulin A vasculitis, VZV-related alopecia, ulcerative varicella skin lesions, childhood herpes zoster (HZ), prolonged prodromal pains, recurrent HZ, VZV implication in burning mouth syndrome, verruciform VZV lesions, the significance of satellite lesions during HZ, and late HZ complications, either neurological or internal. Furthermore, certain associations between the occurrence of HZ and subsequent internal pathologies, as well as risk factors for HZ and new developments in vaccination against HZ will be addressed.

Entities:  

Keywords:  Herpes zoster; Risk factors; Skin; Treatment; Vaccination

Mesh:

Substances:

Year:  2017        PMID: 28197697     DOI: 10.1007/s00105-016-3920-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  32 in total

1.  Adult asthma is associated with an increased risk of herpes zoster: A population-based cohort study.

Authors:  Yi-Hao Peng; Hsin-Yu Fang; Biing-Ru Wu; Chia-Hung Kao; Hsuan-Ju Chen; Te-Chun Hsia; Wei-Chih Liao
Journal:  J Asthma       Date:  2016-07-13       Impact factor: 2.515

2.  Early application of low-level laser may reduce the incidence of postherpetic neuralgia (PHN).

Authors:  Yu-Tsung Chen; Hsiao-Han Wang; Tsung-Jen Wang; Yu-Chuan Li; Ting-Jui Chen
Journal:  J Am Acad Dermatol       Date:  2016-09       Impact factor: 11.527

3.  Ulcerative skin lesions following varicella infection.

Authors:  Monika Tasani; Justin Daniels; Jemima Mellerio; Anna Martinez
Journal:  Arch Dis Child       Date:  2016-09-21       Impact factor: 3.791

4.  Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Authors:  Anthony L Cunningham; Himal Lal; Martina Kovac; Roman Chlibek; Shinn-Jang Hwang; Javier Díez-Domingo; Olivier Godeaux; Myron J Levin; Janet E McElhaney; Joan Puig-Barberà; Carline Vanden Abeele; Timo Vesikari; Daisuke Watanabe; Toufik Zahaf; Anitta Ahonen; Eugene Athan; Jose F Barba-Gomez; Laura Campora; Ferdinandus de Looze; H Jackson Downey; Wayne Ghesquiere; Iris Gorfinkel; Tiina Korhonen; Edward Leung; Shelly A McNeil; Lidia Oostvogels; Lars Rombo; Jan Smetana; Lily Weckx; Wilfred Yeo; Thomas C Heineman
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

Review 5.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

6.  Revisiting childhood herpes zoster.

Authors:  Arjen F Nikkels; Nazli Nikkels-Tassoudji; Gérald E Piérard
Journal:  Pediatr Dermatol       Date:  2004 Jan-Feb       Impact factor: 1.588

Review 7.  Human herpes viruses in burn patients: A systematic review.

Authors:  Paul Wurzer; Ashley Guillory; Daryousch Parvizi; Robert P Clayton; Ludwik K Branski; Lars-P Kamolz; Celeste C Finnerty; David N Herndon; Jong O Lee
Journal:  Burns       Date:  2016-08-08       Impact factor: 2.744

Review 8.  Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.

Authors:  Theresa Mallick-Searle; Brett Snodgrass; Jeannine M Brant
Journal:  J Multidiscip Healthc       Date:  2016-09-21

9.  European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.

Authors:  R N Werner; A F Nikkels; B Marinović; M Schäfer; M Czarnecka-Operacz; A M Agius; Z Bata-Csörgő; J Breuer; G Girolomoni; G E Gross; S Langan; R Lapid-Gortzak; T H Lesser; U Pleyer; J Sellner; G M Verjans; P Wutzler; C Dressler; R Erdmann; S Rosumeck; A Nast
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-11-02       Impact factor: 6.166

10.  The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study.

Authors:  S J Cotton; J Belcher; P Rose; S K Jagadeesan; R D Neal
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.